Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol and Atorvastatin in CKD Stage Vd
NCT01820767Phase 3Completed
- Start
- Aug 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paricalcitol oral solution in chronic kidney disease (CKD). Started Aug 2012; status: completed.
02
Drugs
paricalcitol oral solution
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01820767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820767.